Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02332889
Title Phase I/II Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Louisville
Indications

high grade glioma

medulloblastoma

Therapies

Decitabine

Poly ICLC

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
Pediatric Hematology/Oncology University of Louisville Louisville Kentucky 40202 United States Details
University of Louisville, Kosair Children's Charities Pediatric Clinical Research Unit Louisville Kentucky 40202 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field